Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Techniques for inhibiting tumor metastases.

H C Hoover, A S Ketcham

    Cancer
    |January 11, 1975
    PubMed
    Summary

    Hematogenous cancer spread is a major cause of death. Research explores inhibiting metastasis at multiple stages, from primary tumor growth to distant organ colonization, offering new hope for controlling cancer spread.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise.

    Vaccine·2001
    Same author

    Somatostatinoma of the ampulla of vater in celiac sprue.

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2000
    Same author

    Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
    Same author

    Pelvic exenteration for advanced pelvic malignancy.

    Seminars in surgical oncology·1999
    Same author

    Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study.

    Diseases of the colon and rectum·1998
    Same author

    Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998

    Area of Science:

    • Oncology
    • Cancer Biology
    • Translational Medicine

    Background:

    • Hematogenous dissemination is a critical and often fatal mechanism of cancer spread.
    • Understanding the biological processes of metastasis is key to developing effective treatments.
    • Animal models offer insights into potentially inhibiting cancer metastasis in humans.

    Purpose of the Study:

    • To review the biological mechanisms of cancer spread, focusing on hematogenous dissemination.
    • To explore experimental strategies for inhibiting metastasis at various stages.
    • To discuss the potential application of these strategies to human cancers.

    Main Methods:

    • Review of experimental approaches targeting cancer metastasis.
    • Analysis of methods to inhibit tumor cell invasion, release, and distant organ colonization.
    • Examination of agents affecting coagulation and fibrinolysis in the context of metastasis.
    • Consideration of combined therapeutic approaches (chemotherapy, irradiation, immunotherapy, surgery).

    Main Results:

    • Cancer metastasis can be inhibited by targeting primary tumor growth, vessel invasion, tumor cell release, or distant organ entrapment.
    • Experimental agents can normalize tumor vasculature to prevent tumor cell release.
    • Anticoagulant and fibrinolytic agents may inhibit the entrapment of circulating tumor cells.
    • Combined therapeutic strategies show promise for controlling metastatic disease.

    Conclusions:

    • Targeting specific stages of hematogenous metastasis offers potential for controlling cancer spread.
    • Novel therapeutic agents and combined treatment modalities represent promising avenues for managing metastatic cancer.
    • Further research into combined approaches is crucial for improving outcomes in patients with metastatic cancer.

    Related Experiment Videos